Apollo Cancer Centres Collaborates With Accuray to Launch Indian Sub Continent’s FirstRobotic Stereotactic Radiosurgery Program

Chennai, June 25, 2024 – Apollo Cancer Centres (ACC), in association with Accuray, a global provider of radiation therapy devices, today announced the launch of Indian Sub- Continent’s first robotic and stereotactic therapy education centre, Robotic & Stereotactic Radiosurgery Program.This initiative will be established at ACC in Chennai and Bangalore, and will provide advanced radiosurgery educational training to radiation oncologists, physicists, radiation therapists, and technologists from hospitals, cancer centres and other institutions.

The program includes comprehensive discussions, demonstrations, and hands-on training focusing on robotic and stereotactic radiosurgery. This initiative marks a significant milestone in India’s medical education landscape, making world-class training available locally.

Participants will engage in in-depth discussions, and demonstrations ensuring a robust and practical learning experience.

Dr Shankar Vangipuram, Senior Consultant – Radiation Oncology, said, “The launch of the CyberKnife Academia at Apollo Cancer Centre is an exceptional opportunity to enhance skills and knowledge in Robotic & Stereotactic Radiosurgery. Since pioneering CyberKnife Robotic Surgery System in India, lives of several patients have been transformed, redefining Cancer Care in our country. We look forward to sharing valuable expertise and insights during the training program which will enable us to better serve our patients and set new global standards for cancer care.”

Dr. Mahadev Potharaju, Senior Consultant – Radiation Oncology, said, “Introducing this state-of-the-art education centre aligns perfectly with our endeavour to provide top-notch cancer care. The CyberKnife training will enhance the expertise and capabilities of our Oncologists and medical staff, transforming our approach to Cancer Care in India.”

Mr Dinesh Madhavan, President Group Oncology, and International, Apollo Hospital Enterprises Ltd, said, “In the field of cancer care ground-breaking technologies pave the way for highly personalized and effective treatment. The inception of the Robotic Stereotactic Radiotherapy Program by Apollo Cancer Centres and Accuray will advance training facilities for the ASEAN region. It will help equiponcologists, physicists, and therapists with the critical knowledge and skills needed to leverage the latest in CyberKnife technology.”

Ms Suzanne Winter, President & CEO, Accuray, said, “Accuray celebrates the expansion of the CyberKnife® S7™ System to Apollo Cancer Centers in Chennai and Bangalore, showcasing our enduring collaboration with the hospitals to enhance cancer care in India. With its unparalleled precision, the CyberKnife S7 System redefines treatment standards, empowering clinicians to optimize outcomes. Additionally, it enables the delivery of high doses of radiation, typically in 1 to 5 sessions for fast and effective treatments, marking a significant advancement in cancer therapy.”

The CyberKnife System is a non-invasive, robotic radiation therapy device designed to treat tumors with high precision and minimal damage to surrounding healthy tissue. It uses advanced imaging and computerized robotics to deliver highly focused beams of radiation, allowing for the treatment of complex and hard-to-reach tumors.

With an aim to provide a world-class comprehensive training, the Program will benefit aspiring CyberKnife clinicians of Indian Sub-Continent.

By bringing such a high-calibre educational initiative to India, Apollo Cancer Centres continues to lead the way in medical innovation, dedicated to enhancing the skills of healthcare professionals and ultimately, improving patient outcomes across the country.